Monitoring B cell subsets and alloreactivity in kidney transplantation

Transplantation Reviews

Volumn 29, Issue 2, 2015, Pages 45-52

  Crespo, Marta ^a,b   Heidt, Sebastiaan ^c   Redondo, Dolores ^a,b   Pascual, Julio ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; HLA ANTIGEN; ALLOANTIBODY;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; B LYMPHOCYTE; CHRONIC GRAFT REJECTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GRAFT RECIPIENT; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; PATIENT MONITORING; REVIEW; GRAFT REJECTION; IMMUNOLOGICAL MONITORING; PHYSIOLOGY;

B-LYMPHOCYTE SUBSETS; ENZYME-LINKED IMMUNOSPOT ASSAY; GRAFT REJECTION; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MONITORING, IMMUNOLOGIC;

EID: 84928136595     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2015.02.001     Document Type: Review

References (99)

1. Patel R., Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969, 280:735-739.
2. Meier-Kriesche H.U., Schold J.D., Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?. Am J Transplant 2004, 4:1289-1295.
3. Kasiske B.L., Gaston R.S., Gourishankar S., et al. Long-term deterioration of kidney allograft function. Am J Transplant 2005, 5:1405-1414.
4. Moreso F., Hernandez D. Has the survival of the graft improved after renal transplantation in the era of modern immunosuppression?. Nefrologia 2013, 33:14-26.
5. Roelen D.L., Doxiadis I.I., Claas F.H. Detection and clinical relevance of donor specific HLA antibodies: a matter of debate. Transpl Int 2012, 25:604-610.
6. Mohan S., Palanisamy A., Tsapepas D., et al. Donor-specific antibodies adversely affect kidney allograft outcomes. J Am Soc Nephrol 2012, 23:2061-2071.
7. Crespo M., Torio A., Mas V., et al. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?. Transpl Immunol 2013, 29:28-33.
8. Marfo K., Ajaimy M., Colovai A., et al. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies. Transplantation 2014, 98:1082-1088.
9. Hönger G., Hopfer H., Arnold M.L., Spriewald B.M., Schaub S., Amico P. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation 2011, 92:41-47.
10. Crespo M., Pascual M., Tolkoff-Rubin N., et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001, 71:652-658.
11. Wiebe C., Gibson I.W., Blydt-Hansen T.D., et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012, 12:1157-1167.
12. Everly M.J., Rebellato L.M., Haisch C.E., et al. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts. Transplantation 2013, 95:410-417.
13. Pascual J., Pérez-Sáez M.J., Mir M., Crespo M. Chronic renal allograft injury: early detection, accurate diagnosis and management. Transplant Rev (Orlando) 2012, 26:280-290.
14. Racusen L.C., Colvin R.B., Solez K., et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003, 3:708-714.
15. Smith J.D., Banner N.R., Hamour I.M., et al. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant 2011, 11:312-319.
16. Snyder L.D., Wang Z., Chen D.-F., et al. Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients. Chest 2013, 144:226-233.
17. Pascual J., Samaniego M.D., Torrealba J.R., et al. Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2008, 19:812-824.
18. Kaneku H., O'Leary J.G., Banuelos N., et al. De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant 2013, 13:1541-1548.
19. Bachelet T., Couzi L., Lepreux S., et al. Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome. Am J Transplant 2013, 13:2855-2864.
20. Sis B., Jhangri G.S., Riopel J., et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012, 12:1168-1179.
21. Haas M., Sis B., Racusen L.C., et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014, 14:272-283.
22. Sellarés J., Reeve J., Loupy A., et al. Molecular diagnosis of antibody mediated rejection in human kidney transplants. Am J Transplant 2013, 13:971-983.
23. Thaunat Olivier Humoral immunity in chronic allograft rejection: puzzle pieces come together. Transpl Immunol 2012, 26:101-106.
24. Sellares J., de Freitas D.G., Mengel M., et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012, 12:388-399.
25. Loupy A., Lefaucheur C., Vernerey D., et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med 2013, 369:1215-1226.
26. Lynch R.J., Silva I.A., Chen B.J., Punch J.D., Cascalho M., Platt J.L. Cryptic B cell response to renal transplantation. Am J Transplant 2013, 13:1713-1723.
27. Newell K.A., Asare A., Kirk A.O., et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010, 120:1836.
28. Sagoo P., Perucha E., Sawitzki B., et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010, 120:1848.
29. Crespo M., Yelamos J., Redondo D., et al. Circulating NK-cell subsets in renal allograft recipients with anti-HLA donor-specific antibodies. Am J Transplant 2015, [E-Pub].
30. Kwan D.K., Norman A. Letter: identification of two populations of human lymphocytes. Acta Cytol 1974, 18:189-191.
31. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function. Blood 2008, 112:1570-1580.
32. Sanz I., Wei C., Lee F.E., Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol 2008, 20:67-82.
33. Pascual V., Liu Y.J., Magalski A., de Bouteiller O., Banchereau J., Capra J.D. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994, 180:329-339.
34. Jackson S.M., Wilson P.C., James J.A., Capra J.D. Human B cell subsets. Adv Immunol 2008, 98:151-224.
35. Bohnhorst J., Bjorgan M.B., Thoen J.E., Natvig J.B., Thompson K.M. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001, 167:3610-3618.
36. Klein U., Rajewsky K., Küppers R. Human immunoglobulin (Ig)M+ IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998, 188:1679-1689.
37. Agematsu K., Hokibara S., Nagumo H., Komiyama A. CD27: a memory B-cell marker. Immunol Today 2000, 21:204-206.
38. Fecteau J.F., CÔté G., Néron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006, 177:3728-3736.
39. Kaminski D.A., Wei C., Qian Y., Rosenberg A.F., Sanz I. Advances in human B cell phenotypic profiling. Front Immunol 2012 Oct 10, 3:302. 10.3389/fimmu.2012.00302. eCollection 2012.
40. Maecker H.T., McCoy J.P., Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol 2012, 12:191-200.
41. Streitz M., Miloud T., Kapinsky M., et al. Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study. Transplant Res 2013, 2:17.
42. Heidt S., Vergunst M., Anholts J.D., et al. B cell markers of operational tolerance can discriminate acute kidney allograft rejection from stable graft function. Transplantation 2014, [Epub ahead of print].
43. Noorchashm H., Reed A.J., Rostami S.Y., et al. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol 2006 Dec 1, 177:7715-7722.
44. Ng Y.H., Oberbarnscheidt M.H., Chandramoorthy H.C., Hoffman R., Chalasani G. B cells help alloreactive T cells differentiate into memory T cells. Am J Transplant 2010, 10:1970-1980.
45. Sarwal M., Chua M.S., Kambham N., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003, 349:125-138.
46. Tsai E.W., Rianthavorn P., Gjertson D.W., Wallace W.D., Reed E.F., Ettenger R.B. CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation 2006, 82:1769-1773.
47. Steinmetz O.M., Panzer U., Kneissler U., et al. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 2005, 67:1616-1621.
48. Doria C., di Francesco F., Ramirez C.B., et al. The presence of B-cell nodules does not necessarily portend a less favorable outcome to therapy in patients with acute cellular rejection of a renal allograft. Transplant Proc 2006, 38:3441-3444.
49. Bagnasco S.M., Tsai W., Rahman M.H., et al. CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. Am J Transplant 2007, 7:1968-1973.
50. Zarkhin V., Kambham N., Li L., et al. Characterization of intra-graft B cells during renal allograft rejection. Kidney Int 2008, 74:664-673.
51. Thaunat O., Field A.C., Dai J., et al. Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc Natl Acad Sci U S A 2005, 102:14723-14728.
52. Thaunat O., Patey N., Caligiuri G., et al. Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis. J Immunol 2010, 185:717-728.
53. Zarkhin V., Chalasani G., Sarwal M.M. The yin and yang of B cells in graft rejection and tolerance. Transplant Rev 2010, 24:67-78.
54. Kamburova E.G., Koenen H.J., van den Hoogen M.W., Baas M.C., Joosten I., Hilbrands L.B. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS One 2014 Nov 13, 9:e112658.
55. Zarkhin V., Sarwal M.M. The coin toss of B cells in rejection and tolerance: danger versus defense. Semin Immunol 2012, 24:86-91.
56. van de Berg P.J., Hoevenaars E.C., Yong S.L., et al. Circulating lymphocyte subsets in different clinical situations after renal transplantation. Immunology 2012, 136:198-207.
57. Nouël A., Ségalen I., Jamin C., et al. B cells display an abnormal distribution and an impaired suppressive function in patients with chronic antibody-mediated rejection. Kidney Int 2014, 85:590-599.
58. Stolp J., Turka L.A., Wood K.J. B cells with immune-regulating function in transplantation. Nat Rev Nephrol 2014, 10:389-397.
59. Woodle E.S., Rothstein D.M. Clinical implications of basic science discoveries: Janus resurrected-two faces of B cell and plasma cell biology. Am J Transplant 2015, 15:39-43.
60. Wolf S.D., Dittel B.N., Hardardottir F., Janeway C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996, 184:2271-2278.
61. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
62. Ding Q., Yeung M., Camirand G., et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 2011, 121:3645-3656.
63. Yeung M.Y., Ding Q., Brooks C.R., et al. TIM-1 signaling is required for maintenance and induction of regulatory B cells. Am J Transplant 2015, [Epub ahead of print]. 10.1111/ajt.13087.
64. Kalampokis I., Yoshizaki A., Tedde T.F. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 2013, 1:S1.
65. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
66. Iwata Y., Matsushita T., Horikawa M., et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011, 117:530-541.
67. Blair P.A., Norena L.Y., Flores-Borja F., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010, 32:129-140.
68. Flores-Borja F., Bosma A., Ng D., et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 2013, 5:173ra123.
69. Shen P., Roch T., Lampropoulou V., et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014, 507:366-370.
70. Lee K.M., Kim J.I., Stott R., et al. Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells. Am J Transplant 2012, 12:2072-2078.
71. Lee K.M., Stott R.T., Zhao G., et al. TGF-beta-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol 2014.
72. Le Texier L., Thebault P., Lavault A., et al. Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 2011, 11:429-438.
73. Heidt S., Wood K.J. Biomarkers of operational tolerance in solid organ transplantation. Exp Opin Med Diagn 2012, 6:281-293.
74. Silva H.M., Takenaka M.C., Moraes-Vieira P.M., et al. Preserving the B cell compartment favors operational tolerance in human renal transplantation. Mol Med 2012, 18:733-743.
75. Chesneau M., Pallier A., Braza F., et al. Unique B cell differentiation profile in tolerant kidney transplant patients. Am J Transplant 2014, 14:144-155.
76. Pallier A., Hillion S., Danger R., et al. Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010, 78:503-513.
77. Viklicky O., Krystufkova E., Brabcova I., et al. B-cell-related biomarkers of tolerance are up-regulated in rejection-free kidney transplant recipients. Transplantation 2013, 95:148-154.
78. Valujskikh A., Bromberg J.S. Literature watch: implications for transplantation. Am J Transplant 2013, 13:1117.
79. Banchereau J., Rousset F. Growing human B lymphocytes in the CD40 system. Nature 1991, 353:678-679.
80. Rousset F., Peyrol S., Garcia E., et al. Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. Int Immunol 1995, 7:1243-1253.
81. Armitage R.J., Macduff B.M., Spriggs M.K., Fanslow W.C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 1993, 150:3671-3680.
82. Rieben R., Tucci A., Nydegger U.E., Zubler R.H. Self tolerance to human A and B histo-blood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro. Eur J Immunol 1992, 22:2713-2717.
83. Vischer T.L., Werner-Favre C.F., Wen L., Zubler R.H. Quantitative analysis of precursors frequency of rheumatoid factor (RF) producing human B cells. Scand J Rheumatol Suppl 1988, 75:123-126.
84. Mulder A., Kardol M.J., Kamp J., et al. Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals. Clin Exp Immunol 2001, 124:9-15.
85. Han M., Rogers J., Lavingia B., et al. Peripheral blood B cells producing donor-specific HLA antibodies in vitro. Hum Immunol 2009, 70:29-34.
86. Snanoudj R., Claas F.H., Heidt S., Legendre C., Chatenoud L., Candon S. Restricted specificity of peripheral alloreactive memory B cells in HLA-sensitized patients awaiting a kidney transplant. Kidney Int 2015.
87. Mulder A., Eijsink C., Kardol M.J., Stastny P. Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers. J Immunol 2003, 171:6599-6603.
88. Zachary A.A., Kopchaliiska D., Montgomery R.A., Leffell M.S. HLA-specific B cells: 1. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation 2007, 83:982-988.
89. Zachary A.A., Kopchaliiska D., Montgomery R.A., Melancon J.K., Leffell M.S. HLA-specific B cells: 11. Application to transplantation. Transplantation 2007, 83:989-994.
90. Zachary A.A., Lucas D.P., Montgomery R.A., Leffell M.S. Rituximab prevents an anamnestic response in patients with cryptic sensitization to HLA. Transplantation 2013, 95:701-704.
91. Pape K.A., Taylor J.J., Maul R.W., Gearhart P.J., Jenkins M.K. Different B cell populations mediate early and late memory during an endogenous immune response. Science 2011, 331:1203-1207.
92. Taylor J.J., Martinez R.J., Titcombe P.J., et al. Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. J Exp Med 2012, 209:2065-2077.
93. Chen J., Yin H., Xu J., et al. Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig. Am J Transplant 2013, 13:2280-2292.
94. Czerkinsky C.C., Nilsson L.A., Nygren H. A solid-phase enzyme-linked immunospot (ELISPOT) assay for numeration of specific antibody-secreting cells. J Immunol Methods 1983, 65:109-121.
95. Perry D.K., Pollinger H.S., Burns J.M., et al. Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG. Am J Transplant 2008, 8:133-143.
96. Heidt S., Roelen D.L., de Vaal Y.J., et al. A Novel ELlSPOT assay to quantify HLA-specific B cells in HLA-immunized individuals. Am J Transplant 2012, 12:1469-1478.
97. Mulder A., Kardol M.J., Arn J.S., et al. Human monoclonal HLA antibodies reveal interspecies cross reactive swine MHC class I epitopes relevant for xenotransplantation. Mol lmmunol 2010, 47:809-815.
98. Karahan G.E., de Vaal Y.J., Roelen D.L., Buchli R., Claas F.H., Heidt S. Quantification of HLA class II-specific memory B cells in HLA-sensitized individuals. Hum Immunol 2015, [pii: S0198-8859(15)00015-4. EPub].
99. El-Awar N., Nguyen A., Almeshari K., et al. HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines. Hum Immunol 2013, 74:1141-1152.